BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1458 related articles for article (PubMed ID: 19636003)

  • 41. Clinical analysis of postoperative venous thromboembolism risk factors in lung cancer patients.
    Yang Y; Zhou Z; Niu XM; Li ZM; Chen ZW; Jian H; Ai XH; Cheng BJ; Liao ML; Lu S
    J Surg Oncol; 2012 Nov; 106(6):736-41. PubMed ID: 22711667
    [TBL] [Abstract][Full Text] [Related]  

  • 42. D-dimer levels correlate with mortality in patients with acute pulmonary embolism: Findings from the RIETE registry.
    Grau E; Tenías JM; Soto MJ; Gutierrez MR; Lecumberri R; Pérez JL; Tiberio G;
    Crit Care Med; 2007 Aug; 35(8):1937-41. PubMed ID: 17581488
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients.
    Khorana AA; Francis CW; Culakova E; Kuderer NM; Lyman GH
    Cancer; 2007 Nov; 110(10):2339-46. PubMed ID: 17918266
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comorbidities, alone and in combination with D-dimer, as risk factors for recurrence after a first episode of unprovoked venous thromboembolism in the extended follow-up of the PROLONG study.
    Cosmi B; Legnani C; Tosetto A; Pengo V; Ghirarduzzi A; Testa S; Prisco D; Poli D; Tripodi A; Palareti G; ;
    Thromb Haemost; 2010 Jun; 103(6):1152-60. PubMed ID: 20352167
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diagnostic accuracy of the Triage D-dimer test for exclusion of venous thromboembolism in outpatients.
    Ghys T; Achtergael W; Verschraegen I; Leus B; Jochmans K
    Thromb Res; 2008; 121(6):735-41. PubMed ID: 17888501
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Predictive potential of haemostatic biomarkers for venous thromboembolism in cancer patients.
    Ay C; Pabinger I
    Thromb Res; 2012 Apr; 129 Suppl 1():S6-9. PubMed ID: 22682135
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Different cut-off values of quantitative D-dimer methods to predict the risk of venous thromboembolism recurrence: a post-hoc analysis of the PROLONG study.
    Legnani C; Palareti G; Cosmi B; Cini M; Tosetto A; Tripodi A;
    Haematologica; 2008 Jun; 93(6):900-7. PubMed ID: 18443269
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Coagulation and fibrinolytic markers in a two-month follow-up of coronary bypass surgery.
    Parolari A; Colli S; Mussoni L; Eligini S; Naliato M; Wang X; Gandini S; Tremoli E; Biglioli P; Alamanni F
    J Thorac Cardiovasc Surg; 2003 Feb; 125(2):336-43. PubMed ID: 12579103
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Preoperative plasma D-dimer is a predictor of postoperative deep venous thrombosis in colorectal cancer patients: a clinical, prospective cohort study with one-year follow-up.
    Stender MT; Frøkjaer JB; Larsen TB; Lundbye-Christensen S; Thorlacius-Ussing O
    Dis Colon Rectum; 2009 Mar; 52(3):446-51. PubMed ID: 19333044
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Coagulation activation and microparticle-associated coagulant activity in cancer patients. An exploratory prospective study.
    van Doormaal F; Kleinjan A; Berckmans RJ; Mackman N; Manly D; Kamphuisen PW; Richel DJ; Büller HR; Sturk A; Nieuwland R
    Thromb Haemost; 2012 Jul; 108(1):160-5. PubMed ID: 22535219
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Predictive blood coagulation markers for early diagnosis of venous thromboembolism after total knee joint replacement.
    Watanabe H; Madoiwa S; Sekiya H; Nagahama Y; Matsuura S; Kariya Y; Ohmori T; Mimuro J; Hoshino Y; Hayasaka S; Sakata Y
    Thromb Res; 2011 Dec; 128(6):e137-43. PubMed ID: 21839493
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Potential use of D-dimer measurement in patients treated with oral anticoagulant for a venous thromboembolic episode.
    Ombandza-Moussa E; Samama MM; Horellou MH; Elalamy I; Conard J
    Int Angiol; 2003 Dec; 22(4):364-9. PubMed ID: 15153820
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Plasma levels of prothrombin fragment F1+2, D-dimer and prothrombin time correlate with clinical stage and lymph node metastasis in operable gastric cancer patients.
    Kwon HC; Oh SY; Lee S; Kim SH; Han JY; Koh RY; Kim MC; Kim HJ
    Jpn J Clin Oncol; 2008 Jan; 38(1):2-7. PubMed ID: 18258711
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical outcomes and factors predicting development of venous thromboembolic complications in patients with advanced refractory cancer in a Phase I Clinic: the M. D. Anderson Cancer Center experience.
    Vemulapalli S; Chintala L; Tsimberidou AM; Dhillon N; Lei X; Hong D; Kurzrock R
    Am J Hematol; 2009 Jul; 84(7):408-13. PubMed ID: 19437507
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Incidence of venous thromboembolism and the impact on survival in breast cancer patients.
    Chew HK; Wun T; Harvey DJ; Zhou H; White RH
    J Clin Oncol; 2007 Jan; 25(1):70-6. PubMed ID: 17194906
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical probability assessment and D-dimer determination in patients with suspected deep vein thrombosis, a prospective multicenter management study.
    Elf JL; Strandberg K; Nilsson C; Svensson PJ
    Thromb Res; 2009 Feb; 123(4):612-6. PubMed ID: 18514263
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Plasma tissue factor antigen in localized prostate cancer: distribution, clinical significance and correlation with haemostatic activation markers.
    Langer F; Chun FK; Amirkhosravi A; Friedrich M; Leuenroth S; Eifrig B; Bokemeyer C; Francis JL
    Thromb Haemost; 2007 Mar; 97(3):464-70. PubMed ID: 17334515
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Incidence and clinical implications of venous thromboembolism in advanced colorectal cancer patients: the 'GISCAD-alternating schedule' study findings.
    Mandalà M; Barni S; Floriani I; Isa L; Fornarini G; Marangolo M; Mosconi S; Corsi D; Rulli E; Frontini L; Cortesi E; Zaniboni A; Aglietta M; Labianca R
    Eur J Cancer; 2009 Jan; 45(1):65-73. PubMed ID: 19068274
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Venous thromboembolism in colorectal cancer patients with central venous catheters for 5-FU infusion-based pharmacokinetic modulating chemotherapy.
    Yoshikawa R; Yanagi H; Noda M; Ikeuchi H; Nakano H; Gega M; Tsukamoto K; Oshima T; Inoue T; Fujiwara Y; Shoji Y; Sakaki T; Higasa S; Hashimoto-Tamaoki T; Yamamura T
    Oncol Rep; 2005 Apr; 13(4):627-32. PubMed ID: 15756434
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Current criteria to determine the duration of anticoagulant therapy].
    Palareti G
    Recenti Prog Med; 2007 Dec; 98(12):603-6. PubMed ID: 18369033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 73.